Corona Remedies intimated exchanges that audio recording of its Q4 FY26 earnings call with analysts is now available on company website.
The conference call discussed audited financial results for fourth quarter and full year ended March 31, 2026.
Disclosure made pursuant to SEBI LODR Regulation 30 as follow-up to April 30, 2026 intimation letter.